The oversubscribed round was backed by Consilience Ventures, SOSV, and Catapult Ventures to support the development of the GRACE device.
"This investment is a vote of confidence in QV Bioelectronics from sector-expert investors. The funds raised will fuel the next phase of development of the GRACE device, allowing the size of the QV Bioelectronics team to grow in the process. This will take our innovative electric field therapy technology a few steps closer towards the clinic."
The Series B round was co-led by Insight Partners and Dawn Capital to support platform innovation and hiring.
"When we launched Ably five years ago, we had a clear vision that realtime interactions would underpin rather than just augment our everyday digital experiences. Today, our most important daily and digital experiences happen in realtime. It’s business critical now, and organizations realize they must keep up and transform to remain relevant,"
Highland Europe leads a £13m Series A round in insurtech firm Hyperexponential to scale its engineering and commercial teams.
"The insurance industry is experiencing unprecedented growth, with data and technology being critical strategic drivers. Our software provides the tools that new entrants to the sector need in order to get to market with best-in-class analytics, and the functionality that incumbent insurers require in order to transform."
The Series A round was co-led by MTech Capital and Viola FinTech to support platform expansion and financial services growth.
"Given the strong demographic growth in the over 50s across developed countries, we are constantly surprised that most venture funding continues to flow into business models targeting millennials and Gen Z – at the exclusion of support and services for midlifers. With this funding round, we are delighted to bring on board some fantastic new investors who understand the seismic demographic shift underway in society and the opportunity this presents to better serve an under-represented audience."